Care Redesign

Using Big Data to Make Wiser Medical Decisions

Article · December 23, 2015

As the chief information officer of a large academic medical center, I oversee four petabytes of data. Is that “big data”? I have little difficulty storing, securing, and accessing it, so I’m not sure it qualifies as big. To me, the bigness of data is not its absolute size, but the task of transforming it into wisdom.

At Beth Israel Deaconess Medical Center (BIDMC), we use big data to create real-world applications that lead to wise clinical decisions for patients. That’s something any forward-thinking provider must aim for in today’s data-driven health care environment. I’d like to discuss three BIDMC big-data applications that required both technical expertise and leadership — and that have helped our patients, including my family and me.

Patient-Generated Health Data

For most of my life, my blood pressure (BP) has been 110/50 — a boring number that is considered medically reasonable. During an annual physical exam this past summer, it was 170/100. My medical workup suggested no medical cause for this elevated BP, such as heart- or kidney-related problems. My clinician was perplexed: Was this sudden increase caused by a stressful commute (the Massachusetts Turnpike is awful), too much tea (caffeine and theobromine), or work-related anxiety? To find out, we needed data.

I have a Withings BP cuff linked to my iPhone 6 via Bluetooth Low Energy. My iPhone is connected to my clinician’s electronic health record via a new app called BIDMC@Home. Using the cuff, I took my BP before and after commuting, drinking tea, and attending anxiety-provoking meetings — nearly 100 measurements in a week. The raw data were just numbers, although they helped reveal interesting information — that none of my life activities (commuting, tea drinking, work) influence my blood pressure. The problem, logged as a discrete data point in my electronic health record (EHR), turned out to be my parents. My mother has essential hypertension, as did my father. So did their parents. It took 53 years for my genome to catch up with me and manifest as hypertension. What wisdom did we glean from this knowledge?

Well, I have glaucoma (elevated eye pressure, also inherited from my family) and an occasional fast heartbeat, called atrial tachycardia. Both can be treated effectively with beta-blocker medication, as can essential hypertension. Drawing on clinical guidelines, my EHR took all three conditions into account and suggested beta-blockers as the ideal medication for me. Today, with 25 mg of the beta-blocker metoprolol taken at bedtime, all of my conditions are completely controlled without any side effects. In short, the BP data I had gathered telemetrically at home, coupled with information in my EHR, helped my clinician and me make a wise choice about my treatment.

How did we make BIDMC@Home happen at an organizational level? Our IT leaders started by showing how patient-generated health data could tie in with pay-for-performance reimbursement. Their IT strategic-planning exercise, with a 24-month outlook, involved 30 stakeholders on the front lines of patient care. This group saw that new mobile apps for patients (which measure and manage health outcomes) could yield clinical and financial benefits. The idea was presented to BIDMC’s senior-management operating council and then to the Board’s IT oversight committee. With support at all levels, the project was funded, new support staff were hired, and the rollout ensued. Our IT leaders also served on Obama Administration committees that wrote requirements for patient-generated health data into 2018 federal health care IT regulations, thereby ensuring the concept’s longevity.

Precision Medicine

In December 2011, my wife was diagnosed with stage IIIA breast cancer with a specific type of tumor. (For medically minded readers, it was estrogen-positive, progesterone-positive, and HER2-negative.) She was 49 at the time, is Korean, and has no other significant medical problems.

Using I2B2, an open-source tool available at all Harvard hospitals, I was able to ask this big-data question: Of the last 10,000 Asian women near age 50 who were treated for the same tumor, what medications were used, was surgery or radiation necessary, and what were the outcomes? The answer: a combination of taxol, adriamycin, and cytoxan was most effective, but the amount of taxol had to be carefully limited to avoid nerve damage. My wife was treated successfully and is now cancer free.

To launch I2B2, the leaders of that effort assembled a coalition of senior IT people, throughout Harvard’s hospitals, who became early adopters. They developed the policies and technologies needed to query large databases across institutions, thereby attracting national and international audiences. With each new adopter, momentum built, implementation risks diminished, and institutions decided they didn’t want to be left behind. I2B2 is now used by more than 60 academic medical centers globally. And the Obama Administration’s Precision Medicine initiative aims to bring this kind of decision support, using data from large numbers of successfully treated people, to every new patient.

Wise Analysis

For my wife’s case and my own, the data analytics were done retrospectively, not in real time. A computer did not constantly mine data and then alert clinicians to a new finding. Someone had to ask the right questions — in short, to glean information from the numbers and then use knowledge to make wise, analytical choices.

At BIDMC, we now use a tool called “screening sheets” to support continuous data analysis. Experts decide what data elements and what questions are important for common diseases — and that information is built into the screening-sheets tool. As patients receive new medications, lab results, and diagnoses, the electronic health record alerts clinicians when to take action. For example, a patient with newly diagnosed diabetes is automatically enrolled in a protocol that includes eye exams, foot exams, and pneumonia vaccines.  Any gaps in care for the patient are coupled with information about best practices, and the clinician is proactively informed about both so that he or she can make a wise clinical choice.

We will soon incorporate big data from the genome into our screening sheets. As the second human sequenced in the personal genome project, I know the disease risks identified in my DNA. My clinicians, aided by computer-based clinical decision support, can analyze my new lab results and symptoms according to the likelihood that, given my genetic profile, I will experience a particular disease in my lifetime.

To make screening sheets a success, our IT leaders articulated a vision that was consistent with clinicians’ need to improve quality, safety, and efficiency for better population health. Although the clinicians could not pinpoint the specifications they desired, they enthusiastically embraced the resulting functionality — a “list manager” of patients identified by the screening sheets. The list manager might, for example, generate this message: “Of 4,000 patients seen, 372 (9.3%) have a diagnosis of diabetes; 50 of the 372 have not had their recommended pneumonia vaccine this year. Your care manager should contact these 50 patients (listed here) to schedule vaccination.” It’s easy to act on that type of message.

At BIDMC, we don’t overwhelm clinicians with big data but instead reduce their burden by staying one step ahead of what they need to make wise clinical decisions. Our IT leaders “skate where the puck will be” and score important goals for the entire organization and the patients it serves.

Call for submissions:

Now inviting expert articles, longform articles, and case studies for peer review

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From Care Redesign
Murali01_pullquote Home Recovery Care patient satisfaction

No Place Like Home: Bringing Inpatient Care to the Patient

Providing home-based acute care improves patient satisfaction and care quality while reducing costs.

Rating the Raters - Strengths and Weaknesses Assessment of the Four Public Hospital Quality Rating Systems - 2a

Rating the Raters: An Evaluation of Publicly Reported Hospital Quality Rating Systems

Some promising innovation is taking place among organizations that rate hospital performance, but major systemic change is needed in the field to ensure access to meaningful comparisons through better data and relevant metrics, and to establish integrated oversight through robust audits and peer review.

McKee01_pullquote - the need for coordinated care IPUs for Parkinson's disease

Creating “One-Stop Shop” Care for Parkinson’s

Integrated Practice Units (IPUs) can revolutionize the care of specialty disease conditions, and Parkinson’s disease is a good place to start.

Good Shepherd culturally competent hospice care home visit to the widow of a recently deceased patient

Strangers No More: Culturally Competent Add-On Programs for Diverse Seniors

Creating specialized culturally competent programs to improve patient satisfaction and address the unique health care needs of older immigrants.

Kimberly Dennis and David Newton head shots - SunCloud Mental Health Services

Addressing the Lack of Continuity of Care in Mental Health Services

Co-founders of an integrative outpatient treatment center for mental health and addiction discuss the problematic lack of continuity of care between inpatient and outpatient and physical and mental health services.

Epic OB Hemorrhage PPH Risk Assessment Tool and Alerts at PSJH - Preventing Maternal Death

Improving Maternal Safety Through an EMR Risk Assessment

After a mother died of postpartum hemorrhage, Providence St. Joseph Health made organization-wide changes to prevent future maternal deaths and injuries.

Most Health Care Organizations Have Palliative or End-of-Life Care Programs

Survey Snapshot: Challenging the Resistance to “Palliative”

NEJM Catalyst Insights Council members agree that palliative care is gaining traction, but one of many barriers is getting providers over their resistance to the word “palliative.”

The Assessment of Care Tool - Consisting of Six Visual Analog Scales Corresponding with the IOM Six Dimensions of Perfect Care

Real-Time Pursuit of Outcomes That Matter to Patients

A simple and affordable tool to use at the point of care to drive value creation within clinical microsystems.

Many Patients Who Would Benefit from Palliative - End-of-Life Care Do Not Receive It

Care Redesign Survey: The Power of Palliative Care

Our NEJM Catalyst Insights Council survey on palliative care reveals an interesting dichotomy: While the great majority of organizations have a palliative or end-of-life care program, 60% of patients who would benefit from such services don’t receive them.

Heart Safe Motherhood and Way to Health Two-Way Texting for Blood Pressure Monitoring for Postpartum Women with Preeclampsia

Heart Safe Motherhood: Applying Innovation Methodology for Improved Maternal Outcomes

At the Hospital of the University of Pennsylvania, a text message–based blood pressure surveillance program for postpartum women with preeclampsia improved blood pressure management, reduced readmissions, and increased patient and provider satisfaction.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Coordinated Care

141 Articles

Creating “One-Stop Shop” Care for Parkinson’s

Integrated Practice Units (IPUs) can revolutionize the care of specialty disease conditions, and Parkinson’s disease…

Physician Incentives: Importance of the Why

When moving health care providers forward in the world of value-based care and population health,…

Primary Care

196 Articles

No Place Like Home: Bringing Inpatient…

Providing home-based acute care improves patient satisfaction and care quality while reducing costs.

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now